DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH
Delisted
DCPH was delisted on the 10th of June, 2024.
166 hedge funds and large institutions have $1.94B invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 56 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $2.47B → $1.94B (-$527M)
42% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 38
Holders
166
Holding in Top 10
6
Calls
$13.7M
Puts
$8.54M
Top Buyers
| 1 | +$22.8M | |
| 2 | +$21.9M | |
| 3 | +$17M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$15.1M |
| 5 |
O
OrbiMed
New York
|
+$11.4M |
Top Sellers
| 1 | -$29.1M | |
| 2 | -$27.9M | |
| 3 | -$19.5M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$18.2M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$13.9M |